Supporting Respiratory conditions
by BerriQi®

Derived from non-GMO New Zealand Boysenberries and apples, BerriQi® is available as a versatile freeze-dried whole fruit powder. It supports healthy respiratory functions and assists in restoring normal respiratory immune function.

20%

Reduction in Respiratory Symptoms

650 mg

Daily dose

BerriQi contains high concentrations of bioactive polyphenols and anthocyanins which have broad antioxidant and anti-inflammatory effects, as well as more specific effects on alveolar macrophages that leads to reduced mucus production and reduced collagen in the interstitial space where gasses are exchanged. Click here to download file

BerriQi helps to move the immune system from fight mode into healing mode and further resolve symptoms of inflammation. This reduces the severity of symptoms, shortens the time of sickness, and prevents long term damage. Click here to download file

NZ Boysenberries contain 30% more anthocyanins and 31% more Polyphenols than those grown elsewhere in the world. Our proprietary processing protects these anthocyanins and passes their benefits on to BerriQi consumers. Click here to download file

BerriQi®

Immune Balance

Explore how BerriQi® can help balance out your immune system

BerriQi®
is a patented ingredient.

BerriQi has granted patent claims in 3 areas (it varies according to country)

Treating or preventing acute or chronic allergic airway inflammation with BerriQi

Treating or preventing immune cell infiltration in lung tissue with BerriQi

Treating or preventing accumulation of collagen fibres in lung tissue with BerriQi

A separate patent encompasses Boysenberry for use in people experiencing deposits of collagen in the airways that are associated with chronic obstructive pulmonary disease, reactive airway disease, airway fibrosis, or airway remodelling. 

Read the success story of BerriQi and Nutribase

Webinar

Webinar

Learn how BerriQi can help mitigate lasting lung damage from infection, inflammation, and other lung diseases

How BerriQi® works?

BerriQi® activates our lungs’ post-inflammation repair mechanisms. It has been tested in pre-clinical models of airway inflammation stimulated by airway allergens. Outcomes of BerriQi® consumption were:

  • BerriQi® reduced infiltrating inflammatory cell numbers around airways in acute and chronic allergen exposure models

  • BerriQi® reduced airway mucus in acute and chronic allergen exposure models

  • BerriQi® improved breathing parameters in acute allergen exposure models

  • BerriQi® activated the repair mode of alveolar macrophages in chronic allergen exposure models

  • BerriQi® reduced post-inflammatory lung scarring in chronic allergen exposure models

Opportunity to Formulate with BerriQi®

Kick-start your NPD process with scientifically researched formulation concepts (backed by health claims).

BerriQi® and M2 Machrophage

Daily BerriQi® consumption, concurrent with ongoing allergen exposure in preclinical models of chronic airway allergic inflammation, resulted in cleared airways, lower numbers of immune cell infiltrates in the lungs, a reduction in tissue swelling, removal of the abnormally deposited collagen fibres, and strengthening of the walls of the major airways, all clearly demonstrated by lung histology.

Explore the role macrophages play in lung health and how their different states affect your recovery time, and learn how BerriQi can help promote this switch.

Test your finished products before

COMMERCIALIZING IT!

You can use our exclusive Market Acceptance Testing Platform with your target audience to check for effectiveness and gather feedback/ reviews of your product before it goes ‘live’.

Beyond an ingredient

Why BerriQi® is your best choice?

Scientifically proven effectiveness

Fantastic taste

Market Acceptance Testing Platform

Long Shelf-life (36 months)

Feel results in as little as 1 day